Published in Antibiot Khimioter on January 01, 2010
[The diagnosis and surgical procedure in penetrating neck wounds]. Vestn Khir Im I I Grek (1997) 0.84
Correlations between neurograms and locomotor drive potentials in motoneurons during fictive locomotion: implications for the organization of locomotor commands. Prog Brain Res (1999) 0.80
Treatment of Helicobacter pylori positive duodenal ulcers. Lancet (1990) 0.80
Organization of recurrent inhibition and facilitation in motoneuron pools innervating dorsiflexors of the cat hindlimb. Exp Brain Res (1999) 0.79
Coherence between locomotor drive potentials and neurograms of motor pools with variable patterns of locomotion. Ann N Y Acad Sci (1998) 0.78
[Relaparotomy for intra-abdominal hemorrhage]. Acta Chir Iugosl (1990) 0.78
[Gastroesophageal reflux disease and respiratory apparatus pathology: the evidence of interrelation and unsolved problems]. Vestn Ross Akad Med Nauk (2005) 0.78
Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro. Antiviral Res (2003) 0.77
[Quantitative characterization of antagonistic activity of lactobacilli]. Zh Mikrobiol Epidemiol Immunobiol (2004) 0.77
[Helicobacter pylori, endocrine cells of the gastric mucosa, and their function in duodenal ulcer]. Arkh Patol (1996) 0.77
Gastric cancer screening in selected population of Moscow region: retrospective evaluation. Eur Radiol (1999) 0.77
[Antisecretory therapy for prevention of stenoses of bougienage after-burn of esophageal strictures]. Eksp Klin Gastroenterol (2003) 0.77
[Influence of tableted green tea on index the antioxidant status patients with disease digestion organs]. Vopr Pitan (2008) 0.76
[The enhancement of human thermal resistance by the single use of bemitil and fenibut]. Eksp Klin Farmakol (1997) 0.75
[Efficacy of using inulin fortified fermented milk products in patients with functional constipation]. Vopr Pitan (2009) 0.75
[The therapeutic efficacy of cycloferon and the pharmacological activity of interferon inducers]. Ter Arkh (2014) 0.75
[Protective effect of cycloferon in experimental influenza]. Vopr Virusol (2001) 0.75
[INFLUENCE OF ANGIOPROTECTOR DRUGS ON THE EFFICACY OF CYTOSTATIC THERAPY (EXPERIMENTAL STUDY)]. Eksp Klin Farmakol (2016) 0.75
[Pathogenetic therapy of tuberculosis of respiratory organs during sanatorium-and-spa treatment]. Vopr Kurortol Fizioter Lech Fiz Kult (2009) 0.75
[Physiological criteria of regulating the duration of physical work with submaximal power under conditions of limited heat dissipation]. Fiziol Cheloveka (2002) 0.75
[Effect of phenibut, obsidan and their combination on the human functional state in hyperthermia]. Fiziol Cheloveka (1998) 0.75
[The study and identification of the mummified corpses in case of their mass discovery (a case from the expert practice)]. Sud Med Ekspert (2015) 0.75
Effects of cytoflavin and neuronol on morphological changes in the brain and survival of rats with ischemic disturbances in cerebral blood flow. Bull Exp Biol Med (2004) 0.75
[Diagnostic and surgical tactics in cysts of the spleen]. Klin Khir (1988) 0.75
[Acute chlamydial lesions of the nervous system: etiology, diagnosis, clinical aspects]. Klin Med (Mosk) (2002) 0.75
[Effect of cycloferon on the evolution of cervical and vaginal cancer in mice]. Vopr Onkol (2000) 0.75
[Special surgery of blood vessels injuries in abdominal trauma]. Khirurgiia (Mosk) (1997) 0.75
[Spontaneous pneumothorax (diagnosis and treatment)]. Grudn Khir (1984) 0.75
[Perforating face wound plasty with complex revascularized graft flap]. Khirurgiia (Mosk) (2010) 0.75
[Strangulated postoperative diaphragmatic hernia]. Khirurgiia (Mosk) (1989) 0.75
[Use of modified trocar epicystostomy in the surgical treatment of hypospadias in children]. Vestn Khir Im I I Grek (1980) 0.75
[Correction of postischemic reperfusion injury complications by cytoflavin]. Biull Eksp Biol Med (2000) 0.75
Periodic structure of surface fields of the net atmospheric protein aerosol concentration in the outskirts of the city of Novosibirsk. Dokl Biol Sci (2003) 0.75
Neuroprotective effect of cytoflavin during compression injury of the spinal cord. Bull Exp Biol Med (2005) 0.75
[Laparoscopic removal of IUD situated outside the uterus]. Akush Ginekol (Mosk) (1989) 0.75
[Surgical treatment of hypospadias in children by a modified method]. Vestn Khir Im I I Grek (1980) 0.75
[Effectiveness of laparoscopy in the diagnosis of diseases simulating "acute abdomen"]. Vestn Khir Im I I Grek (1989) 0.75
[Efficacy of cytoflavin in the treatment of chronic cerebral ischemia]. Klin Med (Mosk) (2010) 0.75
[Effect of hepatoprotector remaxol infusion on liver function in obstructive jaundice model in rats]. Eksp Klin Farmakol (2010) 0.75
Medical problems of manned space flights onboard orbital stations. Acta Astronaut (1987) 0.75
[Possibility of maintaining the temperature and work capacity of the extremities]. Gig Sanit (1982) 0.75
[Postgraduate training of pharmacists at the Kiev Institute of Physician Postgraduate Training]. Farm Zh (1973) 0.75
[Detoxicating properties of remaxol with respect to multiple organ failure during severe ethanol poisoning]. Eksp Klin Farmakol (2010) 0.75
[Effect of infusion hepatoprotectors on hepatic function in experimental cholestasis]. Khirurgiia (Mosk) (2010) 0.75
[Cycloferon, as an agent in the therapy and urgent prophylaxis of influenza and acute respiratory tract viral infection (multicentre randomized controlled comparative study)]. Antibiot Khimioter (2009) 0.75
[Errors in the diagnosis of traumatic incarcerated diaphragmatic hernia]. Vestn Khir Im I I Grek (1990) 0.75
[Immunomodulator Cycloferon in the comprehensive treatment of patients with acute non-lymphoblastic leukemia]. Vopr Onkol (1999) 0.75
[Meckel's diverticulum in emergency surgery]. Klin Med (Mosk) (1990) 0.75
[Therapeutic efficiency of cytoflavine solution for infusion in emergency conditions]. Klin Med (Mosk) (2010) 0.75
[Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)]. Ter Arkh (2010) 0.75
[Application of different kinds of internal biliary duct drainage in emergency surgery]. Klin Khir (2000) 0.75
[Improvement of natural resistance in children for prophylaxis of influenza and acute respiratory tract viral infections (results of multicenter randomized trials)]. Antibiot Khimioter (2009) 0.75
[Radiotherapy in the complex treatment of destructive forms of pancreatitis]. Klin Med (Mosk) (1990) 0.75
[Combined cycloferon treatment of tuberculosis in patients infected with HIV]. Eksp Klin Farmakol (2010) 0.75
[Neuroprotective effect of cytoflavin in closed craniocerebral trauma]. Eksp Klin Farmakol (2004) 0.75
[The use of cycloferon in the therapy of experimental herpetic keratitis]. Antibiot Khimioter (2000) 0.75
[Experience with the use of the vacuum aspiration method in the early periods of pregnancy]. Feldsher Akush (1991) 0.75
[Preclinical study of Reamberin and Remaxol safety]. Eksp Klin Farmakol (2010) 0.75
Inhibitory effect of synthetic interferon inductor Cycloferone on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. Cancer Lett (2000) 0.75
[Cycloferon--a new domestic preparation for the prophylaxis of influenza and other acute respiratory viral infections]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.75
[Errors in diagnosis and surgical strategy in ruptures of the diaphragm]. Vestn Khir Im I I Grek (2008) 0.75
[The effect of cycloferon administration on the growth of transplantable tumors in rats and mice]. Vopr Onkol (1998) 0.75
[The complex energy correction of chronic brain ischemia]. Zh Nevrol Psikhiatr Im S S Korsakova (2011) 0.75
[Rational pharmacotherapy and correction of immunity disorders in children with chronic hepatitis (clinical review)]. Antibiot Khimioter (2010) 0.75
[Effect of intensive motor activity in different periods of time on the human functional state and efficiency]. Aviakosm Ekolog Med (2009) 0.75
[Reamberin for pathogenetic therapy of acute and chronic viral diseases of the liver]. Klin Med (Mosk) (2010) 0.75
[Up-to-date approach to treatment of inflammatory infections in the maxillofacial region]. Antibiot Khimioter (2009) 0.75
[Kidney trauma in children]. Vestn Khir Im I I Grek (1994) 0.75
Determination of the optimal temperature of a heat carrier introduced into the liquid heated suit to normalize the heat balance under cold conditions. Hum Physiol (1980) 0.75
[Cycloferon in the treatment of infectious diseases]. Antibiot Khimioter (2008) 0.75
[Correction of adverse reactions in antimicrobial therapy of respiratory tract tuberculosis]. Antibiot Khimioter (2008) 0.75
[Errors in the diagnosis and surgical tactics in pregnant women with acute intestinal obstruction]. Khirurgiia (Mosk) (1990) 0.75
[Possibilities for the correction of immune disorders during tuberculosis infection]. Klin Med (Mosk) (2010) 0.75
[Pathogenetically substantiated therapy of patients with virus hepatitis C, quality of life, and the disease outcome risk (clinical survey)]. Antibiot Khimioter (2010) 0.75
[Antiamnesic effect of cytoflavin and neuronol in rats with ischemic impairment of cerebral circulation]. Eksp Klin Farmakol (2004) 0.75
Experimental study of biological activity of angiogen in experimental cardiovascular and hemostasis pathology. Bull Exp Biol Med (2002) 0.75
[Our experience with the organization of independent work of students in the scientific research-medical department of laparoscopy]. Vestn Khir Im I I Grek (1990) 0.75
[Chemotherapy of chronic viral hepatitis B: randomized multicenter investigation results]. Eksp Klin Farmakol (2010) 0.75
[Remaxol restores the liver antioxidant protection system in experimental cyclophosphan-induced injury]. Eksp Klin Farmakol (2011) 0.75
[Changes of integument of animals in general beta-irradiation with Xe133 and Kr85]. Med Radiol (Mosk) (1974) 0.75
[Scientific presentation of the experience of Soviet military medicine in World War II and in the postwar period by the Museum of Military Medicine of the Ministry of Defense of the USSR]. Voen Med Zh (1976) 0.75
[A device for supporting the legs during lymphography]. Vestn Khir Im I I Grek (1989) 0.75
[Treatment of injuries of the superior mesenteric artery]. Klin Khir (1991) 0.75
[Criteria for regulating the amount of thermal load in using a sauna]. Fiziol Cheloveka (2000) 0.75
Kinetics and photophysical mechanism of sunlight photolysis of unstable resmethrin and phenothrin in aerosols and thin films. Bull Environ Contam Toxicol (1996) 0.75
[Surgical choices in injuries of the inferior vena cava]. Klin Khir (1990) 0.75
Effect of neuronol on lifespan and development of spontaneous tumors in SAMP-1 mice with genetically accelerated aging. Bull Exp Biol Med (2003) 0.75
[The use of cycloferon in experimental radiotherapy of tumors]. Vopr Onkol (1999) 0.75
[Studies to substantiate the optimal topography for supplying heat to the human body staying under cold conditions]. Gig Tr Prof Zabol (1976) 0.75
[Cycloferon efficacy of therapy of chronic hepatitis B (results of randomized multicentre study)]. Antibiot Khimioter (2010) 0.75
[Endoscopic dissection of perforating veins: surgical and pharamacoeconomic aspects]. Angiol Sosud Khir (2008) 0.75
[Clinical and morphological changes in the total beta-irradiation (133Xe and 85Kr) of animals]. Med Radiol (Mosk) (1978) 0.75
Residues of insecticides in vegetation and in soil from high dispersed insecticied aerosols. Bull Environ Contam Toxicol (1977) 0.75
[The use of the laser for determining the direction of the shots and the position of the victim's body in gunshot wounds]. Sud Med Ekspert (1990) 0.75
[Effectiveness of cycloferon in treating virus-associated inflammatory gynecologic diseases]. Vopr Virusol (1999) 0.75
[Cycloferon efficacy in viral and bacterial diseases of children (clinical review)]. Antibiot Khimioter (2010) 0.75
[Effect of cycloferon on dissemination of Lewis lung carcinoma in mice and rhabdomyosarcoma ra-23 in rats]. Vopr Onkol (1999) 0.75
[Experimental bases of the use of pharmacologic agents aimed at higher heat resistance of humans as means of individual protection]. Med Tr Prom Ekol (1997) 0.75
[The clinical picture and diagnosis of postoperative intra-abdominal hemorrhages]. Vestn Khir Im I I Grek (1995) 0.75
[Experimental study of cytoprotector effect of succinate-containing drugs on functional activity of liver]. Eksp Klin Farmakol (2010) 0.75